Dow Down 0.02% Nasdaq Up 0.07%

Incyte Corporation (INCY)

-NasdaqGS
73.14 Down 2.40(3.18%) 4:00PM EST
|After Hours : 73.14 0.00 (0.00%) 6:51PM EST
Prev Close:75.54
Open:75.79
Bid:73.14 x 200
Ask:74.19 x 100
1y Target Est:81.08
Beta:0.18
Earnings Date:Feb 10 - Feb 16 (Est.)
Day's Range:70.21 - 75.88
52wk Range:40.30 - 75.88
Volume:7,072,665
Avg Vol (3m):1,149,360
Market Cap:12.36B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 3.18%12.36B
AMGNDown 1.18%123.41B
CELGUp 0.08%88.71B
RHHBYDown 0.37%252.84B

Key Statistics

Forward P/E (1 yr):348.29
P/S (ttm):26.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.12
Quarterly EPS Est (Dec-14) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-7.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback